Cancer pharmacology and drug development focus on the creation of new medications aimed at treating cancer more effectively. This includes understanding the mechanisms of drug action, resistance, and the design of targeted therapies. Recent advances in drug development have led to the emergence of more effective and personalized treatments, offering improved survival rates and reduced side effects for patients. This session will explore the latest advancements in cancer drug development, from preclinical research to clinical trials, and the challenges in bringing these therapies to market.
Tracks:
Track 21-1: Mechanisms of Drug Action
Track 21-2: Targeted Therapies & Drug Resistance
Track 21-3: Preclinical Research
Track 21-4: Clinical Trials
Track 21-5: Personalized Medicine
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
